FDA
-
-
-
-
-
-
-
Nevro Reports First-Quarter 2024 Financial Results
-
-
-
-
-
-
-
Nevro Reports Third Quarter 2022 Financial Results, Narrows Full-Year 2022 Guidance and Raises Revenue Contribution from Painful Diabetic Neuropathy
-
-
-
-
-
-
-
Nevro Reports Second Quarter 2022 Financial Results, Provides Third Quarter 2022 Guidance and Updates Full-Year 2022 Guidance
-
-
-
-
-
-
-
Nevro (NVRO) Granted FDA Approval for Expanded Labeling for its 10 kHz High Frequency Spinal Cord Stimulation System
-
-
-
-
-
-
-
Nevro Announces Settlement of IP Litigation with Nalu Medical
-
-
-
-
-
-
-
Nevro (NVRO) Announces FDA Approval for Senza System for Chronic Pain Associated with PDN
-
-
-
-
-
-
-
Nevro Announces Publication Of Landmark SENZA-PDN Clinical Trial Results In JAMA Neurology
-
322,134 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

